TCS Recognized as a Leader in IDC MarketScape for Life Sciences Drug Safety Services
Summary
Early investments in re-skilling the workforce, building agile workplaces, and developing intellectual property have helped TCS gain significant scale and depth in next-gen technologies. “Our deep domain expertise, broad portfolio of solutions, contextual knowledge of our customers’ businesses, and investments in research, innovation and intellectual property, make us a trusted partner to drive transformation for our customers,” added Debashis Ghosh. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. TCS investments in both Drug Safety specific and industry-agnostic COEs, strong technical understanding of the drug safety space and commitment to innovation makes it a strong partner to address customers growth and transformation agenda," said Alan S Louie, Research Director, IDC Health Insights Life Science R&D Strategies and Technology Research.“Our deep domain expertise, broad portfolio of solutions, contextual knowledge of our customers’ businesses, and investments in research, innovation and intellectual property, make us a trusted partner to drive transformation for our customers,” added Debashis Ghosh.About IDC MarketScapeIDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared.